UBS Group’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Buy |
|
|||||
|
2025
Q1 | $183K | Sell |
|
|||||
|
2024
Q4 | $9.65M | Buy |
|
|||||
|
2024
Q3 | $3.9M | Sell |
|
|||||
|
2024
Q2 | $12M | Sell |
|
|||||
|
2024
Q1 | $26.4M | Buy |
|
|||||
|
2023
Q4 | $5.09M | Sell |
|
|||||
|
2023
Q3 | $8.62M | Buy |
|
|||||
|
2023
Q2 | $7.31M | Sell |
|
|||||
|
2023
Q1 | $8.28M | Sell |
|
|||||
|
2022
Q4 | $10.2M | Buy |
|
|||||
|
2022
Q3 | $1.11M | Sell |
|
|||||
|
2022
Q2 | $1.35M | Sell |
|
|||||
|
2022
Q1 | $5.41M | Sell |
|
|||||
|
2021
Q4 | $5.34M | Sell |
|
|||||
|
2021
Q3 | $8.13M | Buy |
|
|||||
|
2021
Q2 | $5.04M | Buy |
|
|||||
|
2021
Q1 | $92K | Buy |
|
|||||
|
2020
Q4 | $70K | Sell |
|
|||||
|
2020
Q3 | $592K | Sell |
|
|||||
|
2020
Q2 | $1.35M | Sell |
|
|||||
|
2020
Q1 | $4.57M | Sell |
|
|||||
|
2019
Q4 | $10.1M | Sell |
|
|||||
|
2019
Q3 | $8.03M | Buy |
|
|||||
|
2019
Q2 | $4.62M | Sell |
|
|||||
|
2019
Q1 | $4.55M | Sell |
|
|||||
|
2018
Q4 | $8.93M | Buy |
|
|||||
|
2018
Q3 | $13.3M | Buy |
|
|||||
|
2018
Q2 | $4.21M | Buy |
|
|||||
|
2018
Q1 | $2.39M | Buy |
|
|||||
|
2017
Q4 | $319K | Sell |
|
|||||
|
2017
Q3 | $807K | Buy |
|
|||||
|
2017
Q2 | $236K | Buy |
|
|||||
|
2017
Q1 | $8K | Sell |
|
|||||
|
2016
Q4 | $828K | Buy |
|
|||||
|
2016
Q3 | $2K | Sell |
|
|||||
|
2016
Q2 | $227K | Buy |
|
|||||
|
2016
Q1 | $95K | Sell |
|
|||||
|
2015
Q4 | $1.32M | Buy |
|
|||||
|
2015
Q3 | $27K | Buy |
|
|||||
|
2015
Q2 | $31K | Buy |
|
|||||
|
2015
Q1 | $37K | Sell |
|
|||||
|
2014
Q4 | $89K | Buy |
|